Sign in
CRDL Stock Price, Chart, Stats & News
Cardiol Therapeutics Inc.
Save
Cardiol Therapeutics Inc. (CRDL) does not currently pay a dividend.
125.49M
Market cap
–
Current P/E
–
Forward P/E
CRDL chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -249.38% |
ROE | -202.81% |
D/E | 0.01x |
Interest coverage ratio | – |
CRDL valuation
P/E | – |
P/S | – |
P/B | 15.38x |
P/CF | -6.07x |
P/FCF | -7.99x |
P/OCF | -6.07x |
PEG | -0.27x |
EV multiple | -6.49x |
About
Cardiol Therapeutics Inc. is a clinical-stage life sciences firm dedicated to discovering and advancing anti-fibrotic and anti-inflammatory therapies for cardiovascular disease (CVD). Its leading candidate, CardiolRx, is currently undergoing a multi-national, randomized, double-blind, placebo-controlled Phase II/III study. Furthermore, the company is developing a subcutaneous version of CardiolRx, aimed at addressing the cardiac fibrosis and inflammation linked to the onset and progression of heart failure.
Similar securities
Based on sector and market capitalization
Report issue